Lessons From ALLHAT and CATIE
This article was originally published in RPM Report
Executive Summary
Before the US invests billions in a national center on comparative effectiveness, it may be worth considering whether current efforts have any real impact on prescribing practices. Do large-scale clinical trials add anything to the practice of health care?
You may also be interested in...
PCORI In Brief: New Board Member, Funding Opportunities
The Patient-Centered Outcomes Research Institute welcomes UCSF professor Alicia Fernandez to the board, announces pragmatic trials funding opportunity; Senate bids farewell to PCORI champion Max Baucus.
Comparative Effectiveness: The Next Gatekeeper to Commercial Success
The hot new buzzword with policymakers is comparative clinical effectiveness, and everyone has an idea on how to make it work. But major questions remain: what might a national effort look like? And will payors use it to restrict access to new drugs?
Comparative Effectiveness: The Next Gatekeeper to Commercial Success
The hot new buzzword with policymakers is comparative clinical effectiveness, and everyone has an idea on how to make it work. But major questions remain: what might a national effort look like? And will payors use it to restrict access to new drugs?